Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
16
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
9
users have liked this narrative
2
users have commented on this narrative
12
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Core & Main
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
New Locations And Acquisitions Will Extend Geographic Reach
Key Takeaways Strategic expansions and M&A activities are expected to enhance revenue, geographical reach, and market share in the fragmented industry. Diversification into private labels and municipal infrastructure spending drives margin growth and revenue stability.
View narrative
US$64.50
FV
1.0% overvalued
intrinsic discount
4.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
6 days ago
author updated this narrative
Qiagen
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Syndromic Diagnostics And Automation Will Shape Future Healthcare
Key Takeaways Expansion in syndromic diagnostics, automation, and bioinformatics strengthens Qiagen's market position and supports recurring revenue and margin growth through new products and partnerships. Strategic efficiency initiatives, operational focus, and innovation reinvestment enable Qiagen to scale while returning capital to shareholders and boosting long-term profitability.
View narrative
US$52.39
FV
6.1% undervalued
intrinsic discount
6.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
6 days ago
author updated this narrative
CACI International
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
Robust Government Funding And Digital Transformation Will Expand Addressable Markets
Key Takeaways Expanding government funding and rapid tech adoption are increasing CACI's market opportunities, revenue growth, and contract quality in national security and defense. Strategic acquisitions and sustained digital transformation initiatives strengthen CACI's competitive positioning, margin expansion, and long-term contract visibility.
View narrative
US$541.92
FV
10.2% undervalued
intrinsic discount
6.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
6 days ago
author updated this narrative
Solventum
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Commercial Restructuring And New Product Launches Will Broaden International Reach
Key Takeaways Strong commercial restructuring, innovation pipeline, and international expansion are driving growth, margin improvement, and diversification across core markets and new healthcare technologies. Operational streamlining, portfolio optimization, and disciplined capital allocation are set to boost cash flow, support targeted acquisitions, and enhance overall profitability.
View narrative
US$87.00
FV
16.9% undervalued
intrinsic discount
1.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
6 days ago
author updated this narrative
MakeMyTrip
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Broadening Online Travel Adoption Will Redefine Market Opportunities
Key Takeaways Expanding digital adoption and shifting consumer preferences support long-term growth in bookings, revenues, and market share for MakeMyTrip. Product innovation and integration of ancillary services drive improved margins, higher customer retention, and enhanced pricing power against smaller competitors.
View narrative
US$120.11
FV
15.5% undervalued
intrinsic discount
22.18%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
6 days ago
author updated this narrative
Charles River Laboratories International
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Advanced Therapeutics Adoption Will Transform Preclinical Capabilities
Key Takeaways Expansion into advanced therapeutics and investments in automation and digitalization position the company for higher-margin growth and resilience amid regulatory changes. Strategic cost management, capability diversification, and regulatory resolutions support profitability and position the company for long-term operational stability.
View narrative
US$168.75
FV
6.1% undervalued
intrinsic discount
2.54%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
6 days ago
author updated this narrative
Crown Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Sustainable Packaging And Capacity Expansion Will Strengthen Global Position
Key Takeaways Rising demand for sustainable metal packaging and capacity expansions in key markets are fueling growth, market share gains, and margin improvement. Enhanced operational efficiency and robust free cash flow enable increased shareholder returns and ongoing earnings momentum.
View narrative
US$123.36
FV
18.8% undervalued
intrinsic discount
3.35%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
6 days ago
author updated this narrative
Sociedad Química y Minera de Chile
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Expanding Lithium And Iodine Production Will Meet Growing Demand In EV And Medical Markets
Key Takeaways SQM's strategic investments in lithium and iodine capacity expansion are aimed at capturing growing demand and supporting revenue and earnings growth. A strong financial position allows SQM to invest in expansion and leverage market opportunities, enhancing potential future earnings and shareholder value.
View narrative
US$48.52
FV
7.1% undervalued
intrinsic discount
11.75%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
66
users have followed this narrative
6 days ago
author updated this narrative
Evercore
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Robey Warshaw Acquisition Will Expand Global Advisory Footprint
Key Takeaways Expansion through strategic acquisitions and international growth positions Evercore to capture more advisory revenue and benefit from cross-border M&A trends. Diversification into non-M&A services and investments in senior talent and technology enhance earnings stability and support premium margins.
View narrative
US$345.00
FV
12.5% undervalued
intrinsic discount
18.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
6 days ago
author updated this narrative
Value any company in seconds
Popular companies